10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001628280-22-028692`
Period End Date	20220930
Filing Date	20221107
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	ameh-20220930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 113 Income Statement 80 Cash Flow Statement 133 Stockholders Equity 67

Balance Sheet 113 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$184.02M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$233.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.47M	USD	Point-in-time
Investments in marketable securities	`MarketableSecuritiesCurrent`	$53.42M	USD	Point-in-time
Investments in marketable securities	`MarketableSecuritiesCurrent`	$33.28M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$69.39M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$10.61M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$69.38M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$91.21M	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$12.22M	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	-	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$41.80M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$9.65M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$18.64M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$11.70M	USD	Point-in-time
Loan receivable related party	`NotesAndLoansReceivableNetCurrent`	$4.00M	USD	Point-in-time
Loan receivable related party	`NotesAndLoansReceivableNetCurrent`	-	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	44.88M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	44.63M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	44.88M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	44.63M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$398.78M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$443.62M	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	10.93M	shares	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	11.18M	shares	Point-in-time
Land, property, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$53.19M	USD	Point-in-time
Assets	`Assets`	$943.41M	USD	Point-in-time
Assets	`Assets`	$852.36M	USD	Point-in-time
Land, property, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$104.15M	USD	Point-in-time
Liabilities	`Liabilities`	$390.08M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$73.23M	USD	Point-in-time
Liabilities	`Liabilities`	$336.36M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$82.81M	USD	Point-in-time
Goodwill	`Goodwill`	$253.04M	USD	Point-in-time
Goodwill	`Goodwill`	$257.48M	USD	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetNoncurrent`	$518.00K	USD	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetNoncurrent`	$569.00K	USD	Point-in-time
Loans receivable related parties	`NotesReceivableRelatedPartiesNoncurrent`	$2.12M	USD	Point-in-time
Loans receivable related parties	`NotesReceivableRelatedPartiesNoncurrent`	-	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$41.72M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$38.95M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$16.34M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.44M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.10M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.93M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$499.79M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$453.58M	USD	Point-in-time
Total assets	`Assets`	$943.41M	USD	Point-in-time
Total assets	`Assets`	$852.36M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$43.95M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$47.37M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$6.51M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$10.53M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$55.78M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$42.87M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$94.88M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$50.33M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	-	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$652.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$556.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$556.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$509.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$486.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.21M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.63M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$780.00K	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.16M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$115.37M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$156.19M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$9.13M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$4.70M	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$931.00K	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$973.00K	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$13.20M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$16.14M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$199.15M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$182.92M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$12.96M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$14.78M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$233.89M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$220.99M	USD	Point-in-time
Total liabilities	`Liabilities`	$390.08M	USD	Point-in-time
Total liabilities	`Liabilities`	$336.36M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$55.51M	USD	Point-in-time
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$39.82M	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 44,884,522 and 44,630,873 shares issued and outstanding, excluding 11,175,702 and 10,925,702 treasury shares, as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$45.00K	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 44,884,522 and 44,630,873 shares issued and outstanding, excluding 11,175,702 and 10,925,702 treasury shares, as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$45.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$315.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$310.88M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$195.28M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$143.63M	USD	Point-in-time
Total stockholders' equity, parent	`StockholdersEquity`	$510.44M	USD	Point-in-time
Total stockholders' equity, parent	`StockholdersEquity`	$454.55M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$3.07M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$5.94M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$513.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$404.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$479.52M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$460.49M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$440.32M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$349.69M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$485.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Total liabilities, mezzanine equity, and stockholders equity	`LiabilitiesAndStockholdersEquity`	$852.36M	USD	Point-in-time
Total liabilities, mezzanine equity, and stockholders equity	`LiabilitiesAndStockholdersEquity`	$943.41M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$227.12M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$317.00M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$849.96M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$578.82M	USD	3 Qtrs
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$147.47M	USD	1 Quarter
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$691.57M	USD	3 Qtrs
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$424.30M	USD	3 Qtrs
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$240.77M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$21.81M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$53.22M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$45.48M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$21.39M	USD	1 Quarter
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$13.11M	USD	3 Qtrs
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$4.75M	USD	1 Quarter
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$13.48M	USD	3 Qtrs
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$4.67M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$266.91M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$482.88M	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$758.27M	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$173.96M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$53.16M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$50.09M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$95.93M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$91.69M	USD	3 Qtrs
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.45M	USD	1 Quarter
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$132.00K	USD	1 Quarter
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$4.40M	USD	3 Qtrs
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-3.68M	USD	3 Qtrs
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$2.19M	USD	1 Quarter
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	3 Qtrs
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$2.19M	USD	3 Qtrs
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$967.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$2.42M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.34M	USD	3 Qtrs
Interest expense	`InterestExpense`	$5.35M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$690.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$420.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.33M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$223.00K	USD	1 Quarter
Unrealized (loss) gain on investments	`UnrealizedGainLossOnInvestments`	$-60.94M	USD	1 Quarter
Unrealized (loss) gain on investments	`UnrealizedGainLossOnInvestments`	$22.83M	USD	3 Qtrs
Unrealized (loss) gain on investments	`UnrealizedGainLossOnInvestments`	$-17.59M	USD	3 Qtrs
Unrealized (loss) gain on investments	`UnrealizedGainLossOnInvestments`	$-6.76M	USD	1 Quarter
Other (expense) income	`OtherNonoperatingIncomeExpense`	$-1.32M	USD	1 Quarter
Other (expense) income	`OtherNonoperatingIncomeExpense`	$500.00K	USD	1 Quarter
Other (expense) income	`OtherNonoperatingIncomeExpense`	$-14.08M	USD	3 Qtrs
Other (expense) income	`OtherNonoperatingIncomeExpense`	$2.33M	USD	3 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$4.25M	USD	3 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-15.52M	USD	3 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-8.83M	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-58.66M	USD	1 Quarter
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.50M	USD	1 Quarter
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$76.16M	USD	3 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$41.26M	USD	1 Quarter
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$100.18M	USD	3 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$13.87M	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-120.00K	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$26.10M	USD	3 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$31.57M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$50.06M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$68.60M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-5.38M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$27.40M	USD	1 Quarter
Net income (loss) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.41M	USD	1 Quarter
Net income (loss) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$8.52M	USD	3 Qtrs
Net income (loss) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.59M	USD	3 Qtrs
Net income (loss) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-39.66M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$25.99M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$51.65M	USD	3 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$34.28M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$60.09M	USD	3 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$1.38	USD	3 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.58	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$1.15	USD	3 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.77	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.74	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.56	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.12	USD	3 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.33	USD	3 Qtrs

Cash Flow Statement 133 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$50.06M	USD	3 Qtrs
Net income	`ProfitLoss`	$68.60M	USD	3 Qtrs
Net income	`ProfitLoss`	$-5.38M	USD	1 Quarter
Net income	`ProfitLoss`	$27.40M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$13.48M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$13.11M	USD	3 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$900.00K	USD	3 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$703.00K	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$4.32M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$10.48M	USD	3 Qtrs
Gain on sale of investments	`GainOnSaleOfInvestments`	$2.19M	USD	3 Qtrs
Gain on sale of investments	`GainOnSaleOfInvestments`	$2.27M	USD	3 Qtrs
Unrealized loss (gain) on investments	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$-21.89M	USD	3 Qtrs
Unrealized loss (gain) on investments	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$22.83M	USD	3 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.45M	USD	1 Quarter
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$132.00K	USD	1 Quarter
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$4.40M	USD	3 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-3.68M	USD	3 Qtrs
Impairment of beneficial interest	`AssetImpairmentCharges`	$15.72M	USD	3 Qtrs
Impairment of beneficial interest	`AssetImpairmentCharges`	-	USD	3 Qtrs
Unrealized (gain) loss on interest rate swaps	`UnrealizedGainLossOnDerivatives`	$4.30M	USD	3 Qtrs
Unrealized (gain) loss on interest rate swaps	`UnrealizedGainLossOnDerivatives`	$-1.07M	USD	3 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-2.33M	USD	3 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$6.85M	USD	3 Qtrs
Other	`ProceedsFromOtherOperatingActivities`	$901.00K	USD	3 Qtrs
Other	`ProceedsFromOtherOperatingActivities`	$189.00K	USD	3 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$10.69M	USD	3 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$58.33M	USD	3 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$4.37M	USD	3 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$21.83M	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$31.99M	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$1.48M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-3.23M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-5.06M	USD	3 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$2.44M	USD	3 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$2.84M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$682.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$954.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$14.36M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$765.00K	USD	3 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-815.00K	USD	3 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-4.03M	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-7.63M	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$37.49M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-14.55M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-300.00K	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.06M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.53M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$3.12M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.81M	USD	3 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$82.53M	USD	3 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$2.58M	USD	3 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$5.61M	USD	3 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$41.00K	USD	3 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$4.05M	USD	3 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.75M	USD	3 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.01M	USD	3 Qtrs
Purchase of investment equity method	`PaymentsToAcquireEquityMethodInvestments`	$13.38M	USD	3 Qtrs
Purchase of investment equity method	`PaymentsToAcquireEquityMethodInvestments`	-	USD	3 Qtrs
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	$6.38M	USD	3 Qtrs
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.05M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$16.42M	USD	3 Qtrs
Cash received from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	$3.32M	USD	3 Qtrs
Cash received from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	-	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.11M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$6.44M	USD	3 Qtrs
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	3 Qtrs
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$400.00K	USD	3 Qtrs
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	-	USD	3 Qtrs
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	$1.78M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-22.54M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.31M	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$31.09M	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$12.68M	USD	3 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$238.25M	USD	3 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$3.71M	USD	3 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$81.00K	USD	3 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$27.00K	USD	1 Quarter
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$417.00K	USD	3 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$138.00K	USD	1 Quarter
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$6.60M	USD	3 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$2.78M	USD	3 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$5.74M	USD	3 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$9.65M	USD	3 Qtrs
Proceeds from sale of non-controlling interest	`ProceedsFromSaleOfNoncontrollingInterest`	$67.00K	USD	3 Qtrs
Proceeds from sale of non-controlling interest	`ProceedsFromSaleOfNoncontrollingInterest`	$48.00K	USD	3 Qtrs
Purchase of non-controlling interest	`PaymentsToAcquireNonControllingInterest`	$75.00K	USD	3 Qtrs
Purchase of non-controlling interest	`PaymentsToAcquireNonControllingInterest`	$4.34M	USD	3 Qtrs
Borrowings on loans	`ProceedsFromIssuanceOfDebt`	$180.00M	USD	3 Qtrs
Borrowings on loans	`ProceedsFromIssuanceOfDebt`	$1.99M	USD	3 Qtrs
Proceeds from sale of shares	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from sale of shares	`ProceedsFromIssuanceOfCommonStock`	$40.13M	USD	3 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$727.00K	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-49.18M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-25.96M	USD	3 Qtrs
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$10.80M	USD	3 Qtrs
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-49.08M	USD	3 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.02M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.77M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.02M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.77M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$24.80M	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$41.81M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$3.33M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$4.39M	USD	3 Qtrs
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	$71.00K	USD	Point-in-time
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	-	USD	Point-in-time
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilitiesAdjustedToGoodwill`	$1.79M	USD	3 Qtrs
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilitiesAdjustedToGoodwill`	-	USD	3 Qtrs
Fixed asset obtained in exchange for finance lease liabilities	`RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability`	-	USD	3 Qtrs
Fixed asset obtained in exchange for finance lease liabilities	`RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability`	$398.00K	USD	3 Qtrs
Common stock issued in business combination	`StockIssued1`	$1.00M	USD	3 Qtrs
Common stock issued in business combination	`StockIssued1`	-	USD	3 Qtrs
Cancellation of restricted stock awards	`CancellationOfRestrictedStockAwards`	-	USD	3 Qtrs
Cancellation of restricted stock awards	`CancellationOfRestrictedStockAwards`	$334.00K	USD	3 Qtrs
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	-	USD	3 Qtrs
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	$16.27M	USD	3 Qtrs
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	-	USD	3 Qtrs
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	$694.00K	USD	3 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$184.02M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$233.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.47M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.02M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.77M	USD	Point-in-time

Stockholders Equity 67 line items

Line Item	Tag	Value	Unit	Period
Temporary equity, carrying amount, beginning balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$55.51M	USD	Point-in-time
Temporary equity, carrying amount, beginning balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$39.82M	USD	Point-in-time
Temporary equity, carrying amount, ending balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$55.51M	USD	Point-in-time
Temporary equity, carrying amount, ending balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$39.82M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$513.51M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$404.58M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$479.52M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$460.49M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$440.32M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$349.69M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$485.85M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$13.70M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$15.20M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$12.67M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$12.74M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$34.97M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$27.41M	USD	1 Quarter
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$75.00K	USD	1 Quarter
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$4.14M	USD	1 Quarter
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$200.00K	USD	1 Quarter
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$36.00K	USD	1 Quarter
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$37.00K	USD	1 Quarter
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$28.00K	USD	1 Quarter
Sale of shares by non-controlling interest	`StockIssuedDuringPeriodValueNoncontrollingInterest`	$40.13M	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-253.00K	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-62.00K	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$4.26M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.05M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$561.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$165.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.78M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.57M	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$342.00K	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$2.95M	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$2.45M	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$9.25M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.56M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.92M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.35M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.06M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.50M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.42M	USD	1 Quarter
Issuance of shares for business acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$1.00M	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$144.00K	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$457.00K	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$189.00K	USD	1 Quarter
Investment in non-controlling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$371.00K	USD	1 Quarter
Investment in non-controlling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$3.77M	USD	1 Quarter
Acquisition of noncontrolling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$500.00K	USD	1 Quarter
Noncontrolling interest capital charge	`NoncontrollingInterestIncreaseFromCapitalCharge`	$10.00K	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	-	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-120.00K	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-1.18M	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-1.37M	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-1.16M	USD	1 Quarter
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$513.51M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$404.58M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$479.52M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$460.49M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$440.32M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$349.69M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$485.85M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.